Steris Corp. (STE) VP John Adam Zangerle Sells 2,200 Shares
Steris Corp. (NYSE:STE) VP John Adam Zangerle sold 2,200 shares of the company’s stock in a transaction on Tuesday, November 15th. The shares were sold at an average price of $67.00, for a total transaction of $147,400.00. Following the completion of the sale, the vice president now directly owns 26,166 shares in the company, valued at $1,753,122. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Shares of Steris Corp. (NYSE:STE) traded down 0.02% on Thursday, hitting $66.50. 256,072 shares of the company’s stock were exchanged. The stock has a market cap of $5.67 billion, a price-to-earnings ratio of 33.57 and a beta of 1.30. Steris Corp. has a 12-month low of $61.38 and a 12-month high of $78.77. The company’s 50-day moving average price is $68.60 and its 200 day moving average price is $69.68.
Steris Corp. (NYSE:STE) last announced its quarterly earnings data on Wednesday, November 2nd. The company reported $0.89 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.90 by $0.01. Steris Corp. had a net margin of 6.41% and a return on equity of 9.89%. The firm earned $646.40 million during the quarter, compared to analyst estimates of $670.24 million. During the same quarter in the previous year, the business posted $0.83 earnings per share. Steris Corp.’s revenue for the quarter was up 31.9% compared to the same quarter last year. On average, equities analysts predict that Steris Corp. will post $3.90 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 21st. Stockholders of record on Wednesday, November 23rd will be issued a $0.28 dividend. The ex-dividend date is Monday, November 21st. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.68%. Steris Corp.’s payout ratio is 57.14%.
Several large investors have recently made changes to their positions in STE. Whittier Trust Co. of Nevada Inc. raised its stake in shares of Steris Corp. by 8.7% in the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,398 shares of the company’s stock valued at $102,000 after buying an additional 112 shares in the last quarter. Bronfman E.L. Rothschild L.P. raised its stake in shares of Steris Corp. by 26.3% in the third quarter. Bronfman E.L. Rothschild L.P. now owns 1,528 shares of the company’s stock valued at $112,000 after buying an additional 318 shares in the last quarter. Amica Retiree Medical Trust bought a new stake in shares of Steris Corp. during the third quarter valued at approximately $119,000. Bessemer Group Inc. raised its stake in shares of Steris Corp. by 85.8% in the second quarter. Bessemer Group Inc. now owns 1,942 shares of the company’s stock valued at $134,000 after buying an additional 897 shares in the last quarter. Finally, Creative Planning raised its stake in shares of Steris Corp. by 76.9% in the third quarter. Creative Planning now owns 1,838 shares of the company’s stock valued at $134,000 after buying an additional 799 shares in the last quarter. Institutional investors and hedge funds own 91.26% of the company’s stock.
STE has been the topic of several recent research reports. JMP Securities reaffirmed a “buy” rating on shares of Steris Corp. in a report on Friday, November 4th. Zacks Investment Research raised shares of Steris Corp. from a “sell” rating to a “hold” rating in a report on Thursday, September 8th.
Steris Corp. Company Profile
STERIS Corporation (STERIS) is a provider of infection prevention and other procedural products and services. The Company is focused on healthcare, pharmaceutical and research. The Company operates through three business segments: Healthcare, Life Sciences and STERIS Isomedix Services. The Healthcare segment provides surgical, sterile processing, infection prevention and gastrointestinal solutions.
Receive News & Stock Ratings for Steris Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Corp. and related stocks with our FREE daily email newsletter.